Sae Kitano

Everolimus for Treating Hormone Receptor-positive Metastatic Breast Cancer Previously Treated With Cyclin-dependent Kinase 4/6 Inhibitors

A. Honda, Naoko Itoi, Tecchuu Lee, 2022, AntiCancer Research.

Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib

W. Ishii, Y. Naoi, K. Sakaguchi, 2023, AntiCancer Research.

Multi-gene assay 95- and 155-gene classifiers for prognosis prediction and chemotherapy omission in lymphnode positive luminal-type breast cancer.

Y. Naoi, K. Sakaguchi, Chikage Kato, 2023, Cancer treatment and research communications.